Evidence map›Paper›PMID 28071763›Full record

ArticleNature communications2017

Starved epithelial cells uptake extracellular matrix for survival.

Taru Muranen, Marcin P Iwanicki, Natasha L Curry, Julie Hwang, Cory D DuBois, Jonathan L Coloff, Daniel S Hitchcock, Clary B Clish, Joan S Brugge, Nada Y Kalaany

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. In-feedFrontiers in physiology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Engineering metabolism to modulate immunity.Advanced drug delivery reviews · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Breast cancers as ecosystems: a metabolic perspective.Cellular and molecular life sciences : CMLS · 2023
    Review
  17. Article
  18. Metabolic targeting of malignant tumors: a need for systemic approach.Journal of cancer research and clinical oncology · 2023
    Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Taru MuranenDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Marcin P IwanickiDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Natasha L CurryDivision of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
Julie HwangDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cory D DuBoisDivision of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
Jonathan L ColoffDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Daniel S HitchcockBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Clary B ClishBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.ORCID 0000-0001-8259-9245
Joan S BruggeDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nada Y KalaanyDivision of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.ORCID 0000-0001-7489-1035
Harvard University · USBroad Institute · USBoston Children's Hospital · US

Funding

Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI EL-BARDEESY, NABEEL, SELLERS, WILLIAM R · 2007 to 2023
$33.2M
Mechanisms of extracellular matrix mediated drug resistanceR00CA180221 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MURANEN, TARU ELIISA · 2016 to 2018
$747k
Mechanisms of extracellular matrix mediated drug resistanceK99CA180221 · NCI · HARVARD MEDICAL SCHOOL · PI MURANEN, TARU ELIISA · 2013 to 2014
$205k
NCI NIH HHS K99 CA180221NCI NIH HHS P50 CA127003NCI NIH HHS R00 CA180221
6 · The paper itself

Abstract

Extracellular matrix adhesion is required for normal epithelial cell survival, nutrient uptake and metabolism. This requirement can be overcome by oncogene activation. Interestingly, inhibition of PI3K/mTOR leads to apoptosis of matrix-detached, but not matrix-attached cancer cells, suggesting that matrix-attached cells use alternate mechanisms to maintain nutrient supplies. Here we demonstrate that under conditions of dietary restriction or growth factor starvation, where PI3K/mTOR signalling is decreased, matrix-attached human mammary epithelial cells upregulate and internalize β4-integrin along with its matrix substrate, laminin. Endocytosed laminin localizes to lysosomes, results in increased intracellular levels of essential amino acids and enhanced mTORC1 signalling, preventing cell death. Moreover, we show that starved human fibroblasts secrete matrix proteins that maintain the growth of starved mammary epithelial cells contingent upon epithelial cell β4-integrin expression. Our study identifies a crosstalk between stromal fibroblasts and epithelial cells under starvation that could be exploited therapeutically to target tumours resistant to PI3K/mTOR inhibition.

Indexed as

Adipose TissueAnimalsCell LineCell SurvivalEpithelial CellsExtracellular MatrixFemaleFibroblastsHumansIntegrin beta4LamininMechanistic Target of Rapamycin Complex 1Mice, Inbred StrainsPhosphatidylinositol 3-KinasesStarvationIntegrin beta4ITGB4 protein, humanLamininMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-Kinases

Identifiers

PMID28071763
PMCPMC5234072
OpenAlexW2568259763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.